Relief Therapeutics Holding's total inventories for the quarter that ended in Jun. 2025 was $1.14 Mil. Relief Therapeutics Holding's average total inventories from the quarter that ended in Dec. 2024 to the quarter that ended in Jun. 2025 was $1.15 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Relief Therapeutics Holding's Net-Net Working Capital per share for the quarter that ended in Jun. 2025 was $-0.19.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Relief Therapeutics Holding's Days Inventory for the
six
months ended in Jun. 2025 was 285.26.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Relief Therapeutics Holding's Inventory Turnover for the quarter that ended in Jun. 2025 was 0.64.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Relief Therapeutics Holding's Inventory-to-Revenue for the quarter that ended in Jun. 2025 was 0.77.
Relief Therapeutics Holding (OTCPK:RLFTF) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Relief Therapeutics Holding's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2025 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Relief Therapeutics Holding's Inventory to Revenue for the quarter that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Relief Therapeutics Holding Total Inventories Related Terms
Relief Therapeutics Holding Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Relief Therapeutics Holding Total Inventories Chart
Relief Therapeutics Holding Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Relief Therapeutics Holding (RLFTF) has a Total Inventories of $1.14 Mil as of Jun. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Relief Therapeutics Holding and its competitors.
Is Relief Therapeutics Holding's Total Inventories too high?
Relief Therapeutics Holding's current Total Inventories is $1.14 Mil. Overall, Relief Therapeutics Holding has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Relief Therapeutics Holding's Total Inventories compare to KTTA and OSRH?
Relief Therapeutics Holding's Total Inventories of $1.14 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Relief Therapeutics Holding and its competitors. Relief Therapeutics Holding's current Total Inventories is $1.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Relief Therapeutics Holding stock overvalued right now?
Relief Therapeutics Holding (RLFTF) has a current Total Inventories of $1.14 Mil. The stock's GF Value™ is $0.61, compared to a current price of $0.29 — trading 53.3% below its estimated fair value. The current Total Inventories is $1.14 Mil. Relief Therapeutics Holding's overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Relief Therapeutics Holding (RLFTF), the current Total Inventories is $1.14 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Relief Therapeutics Holding (RLFTF) Overvalued in 2026?
Based on GuruFocus' analysis, Relief Therapeutics Holding stock appears to be undervalued.
The current stock price of $0.29 is trading 53.3% below its estimated GF Value™ of $0.61.
Key valuation signals for RLFTF:
Total Inventories: $1.14 Mil
GF Value™: $0.61 vs. price of $0.29 (53.3% below fair value)
No single metric tells the full story. See the RLFTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products, and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development, such as RLF-TD011 and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast, among others. Geographically, the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.
31GF Score
Get the complete analysis for RLFTF
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RLFTF has been successfully added to your 
